Investors & Biotech

The founders have a background as either MD or DVM and have spent more than 20 years in pharmaceutical industry, fulfilling a broad range of functions such as:

Medical director, Head of pre-clinical research, Head of in-licensing.

The group has evaluated more than 400 development projects within all major therapeutic areas and have participated in numerous due diligences and contract negotiations with biotech companies, including final in-licensing deals.

Evaluations have covered early as well as late-stage development projects.

Our main therapeutic area expertise include:

• Cardiovascular
• Hemostasis & thrombosis
• Pain
• Gastroenterology
• Metabolic diseases
• Dermatology
• Urology

We have close working relationships with additional experts and key opinion leaders in the clinical community, who are available on a project basis, as needed.

Project Identification/Assessment including:

• Description of disease and market
• Unmet medical need
• Medical utility / differentiation
• Product characterisation
• Competitive environment
• Development feasibility
• Target product profile
• Regulatory and IP assessment
• Risk assessment
• Recommendation

Project Strategy & Development including:

• Recommandations for strategic development optimisation
• Proposal for pre-clinical and clinical development plans
• Medical /scientific input to business plan
• Project management
• Ad hoc general management